Although further investigation is necessary to clarify the precise mechanisms by which Derlin-1 and Derlin-2 regulate SREBP-2 activation, we propose that Derlins may be a therapeutic target to ameliorate or delay the progression of neurodegenerative diseases. Here, DERL1 is linked to neurodegenerative disease.